Answers are grounded in this paper and cite their sources.
In response to the epidemiological situation, live attenuated or killed vaccines against anthrax, brucellosis, cholera, glanders, plague and tularemia were developed and used for immunization of at-risk populations in the Former Soviet Union. Certain of these vaccines have been updated and currently they are used on a selective basis, mainly for high risk occupations, in the Russian Federation. Except for anthrax and cholera these vaccines currently are the only licensed products available for protection against the most dangerous bacterial pathogens. Development of improved formulations and new products is ongoing.
No takes yet. Share an insight, caveat, or question.
Feodorova et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: